Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Clinical trial NCT02474420 · UNKNOWN

Trial details

NCT number: NCT02474420
Sponsor: Kevin H.M. Kuo, MD, MSc, FRCPC
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Beta-Thalassemia Iron Overload

Start date: 2015-06-01
Primary completion: 2017-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.